Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma. - Wikidata - awgldk - TriplyDB

Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma.

Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma.

http://www.wikidata.org/entity/Q36485509

about

Assessing the Methodology for Calculating Platelet Contribution to Clot Strength (Platelet Component) in Thromboelastometry and Thrombelastography The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition Thrombelastography (TEG®): practical considerations on its clinical use in trauma resuscitation Acquired hypofibrinogenemia: current perspectives TACTIC: Trans-Agency Consortium for Trauma-Induced Coagulopathy Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review Fibrinogen concentrate improves survival during limited resuscitation of uncontrolled hemorrhagic shock in a Swine model.Trauma-Induced Coagulopathy: An Institution's 35 Year Perspective on Practice and Research.Fibrinogen and platelet contributions to clot formation: implications for trauma resuscitation and thromboprophylaxis Detection of acute traumatic coagulopathy and massive transfusion requirements by means of rotational thromboelastometry: an international prospective validation study.Thromboelastography: A Practice Summary for Nurse Practitioners Treating Hemorrhage Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients.Platelets are dominant contributors to hypercoagulability after injury Reduced Transfusion During OLT by POC Coagulation Management and TEG Functional Fibrinogen: A Retrospective Observational Study.Importance of fibrinogen in dilutional coagulopathy after neurosurgical procedures: A descriptive study Postinjury hyperfibrinogenemia compromises efficacy of heparin-based venous thromboembolism prophylaxis.Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy.Thrombelastography indicates limitations of animal models of trauma-induced coagulopathy.Determination of non-Vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system.Management of Trauma-Induced Coagulopathy with Thrombelastography.Optical sensing of anticoagulation status: Towards point-of-care coagulation testing.Viscoelastic hemostatic fibrinogen assays detect fibrinolysis early.The hypercoagulability paradox of chronic kidney disease: The role of fibrinogen.Optimizing transfusion strategies in damage control resuscitation: current insights

P2860

Q26785877-13491999-7096-4E4E-9CEC-CBC941BE436C Q27339343-913EA158-C321-4185-8C21-DAC71053D836 Q27499191-F101ED83-A89A-4FA9-857B-E8AD43809FE8 Q28077374-7005C98A-F4B3-48D2-B999-9272150527E1 Q28083939-23C3545F-1867-4271-A71B-C8A0B862387D Q30595449-229FBDFA-98BB-4517-BAD3-4B33EAC32E52 Q34390320-13E1E237-D785-424D-94B0-6A690C2F557B Q34429408-D21F632C-D987-4FDE-904A-CC0AC8BEAD58 Q34549143-25F10B73-ADF3-46DF-B958-10CDD403DFC1 Q35218708-34ACCE3D-D2B6-49D5-BE1B-5638A9212A16 Q35926609-7D644411-62AE-458B-84D4-C4791B2A9A7B Q36818081-85C4C824-A138-491B-BE97-6FC48EC87B16 Q37078508-0AB5CEBB-AB78-4FFE-A952-7EFD31BFAE1B Q37097789-75F059D2-401C-4634-A889-DB390E9B8A1D Q37186526-875B8BAD-F18E-4643-AB6A-E6B94084719C Q37518149-602CF470-E244-4E6F-9235-11AC1378A269 Q37731832-F734A8A5-D1A0-4A39-82AF-6C0F239F65C9 Q38742341-8AA22AB6-8FE7-4128-B53E-B9E7B6F74741 Q38936364-4DA27C3F-CA05-4CB8-B872-2B9213EF3C37 Q39022502-11D9482A-D86F-4197-880B-0A1756A6DC3D Q41238308-A47E1253-06C7-42DE-9CA6-DA01A9D89E5A Q49164696-E986865C-8EC5-40C0-8BB2-D8F30BDF8093 Q49815468-9A186932-CCE5-4DBE-BCC6-3179CC9F3E99 Q58735789-9996EDAF-45B1-4D1D-B1C9-A2FDCEA797B7

P2860

Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma.

http://www.wikidata.org/entity/Q36485509

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Functional fibrinogen assay in ...... lot strength following trauma.

@ast

Functional fibrinogen assay in ...... lot strength following trauma.

@en

type

label

Functional fibrinogen assay in ...... lot strength following trauma.

@ast

Functional fibrinogen assay in ...... lot strength following trauma.

@en

prefLabel

Functional fibrinogen assay in ...... lot strength following trauma.

@ast

Functional fibrinogen assay in ...... lot strength following trauma.

@en

P1433

Q36485509-2F397870-3AA2-4A16-81C0-CF542BEB44A8

P1476

Q36485509-74B24BBD-C8A6-4D28-B0F5-46591BD9D3B0

P2093

Q36485509-519CF056-DC1A-496F-97AA-B3AE15D2EF64

Q36485509-9E9CB3F1-DB39-41C7-9249-4EB8800B44C9

Q36485509-B75850D4-6A96-436A-8772-449AD8494D02

Q36485509-E170F956-F88D-4D1D-ABE4-C37B3DE8E494

Q36485509-E8C30C21-6B08-41AD-B120-4F55AE5BBF0B

P2860

Q36485509-225DDAB0-266F-4ED0-A78D-D06F28770360

Q36485509-31CB4A1E-6979-45BA-A7BF-95179EBC4386

Q36485509-34C194CF-D8CA-49B4-B664-B0B0D02995AD

Q36485509-440B6338-6D47-4C67-8DA2-08C18C33FB64

Q36485509-591710A2-EC7A-4C6A-931B-7B4087F059FB

Q36485509-59E3A9DD-F28D-4737-B1C9-2760B8AE4B80

Q36485509-5DB63183-58DF-4A43-A481-EAADD8560227

Q36485509-617E987D-79D8-4CE5-B3E2-823E0E8A0EBB

Q36485509-6B17BE48-BEDD-4988-8CC2-F5D25B4EAA6B

Q36485509-6F72903C-1DD9-4190-8789-3BE7A68BEEC8

P304

Q36485509-CA8DB88B-4A73-47F3-A1C8-46FB157D92C4

P31

Q36485509-DDFD8D8A-4A60-4BB7-95DF-713130C6C3A7

P356

Q36485509-0ECD3CE3-61CB-44DD-99AB-143A74A99655

P433

Q36485509-BEA25A76-1358-435D-A20A-5663A0D4C0E0

P478

Q36485509-15B6D738-EDDD-4C19-AE1C-6FEE5FE6F340

P50

Q36485509-8B3887B8-C5A8-40F5-9304-3240062A4467

Q36485509-E94E65F8-0C30-489F-B504-15BD49579DFF

P577

Q36485509-0E0DDEA0-6668-46D1-BF80-BAEC393FE6D1

P698

Q36485509-7084D91B-089D-4D89-9892-15D34F85097D

P932

Q36485509-6E162B66-8D9E-4B01-8E8D-C109C6E505ED

P356

SHK.0B013E3182787122

P1433

P1476

Functional fibrinogen assay in ...... clot strength following trauma

@en

P2093

Angela Sauaia

http://www.w3.org/2001/XMLSchema#string

Arsen Ghasabyan

http://www.w3.org/2001/XMLSchema#string

Christopher C Silliman

http://www.w3.org/2001/XMLSchema#string

Ernest E Moore

http://www.w3.org/2001/XMLSchema#string

Theresa L Chin

http://www.w3.org/2001/XMLSchema#string

P2860

A cell-based model of hemostasis

Epidemiology of trauma deaths: a reassessment

Hemostasis in massively transfused trauma patients.

Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate

Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy.

Early platelet dysfunction: an unrecognized role in the acute coagulopathy of trauma.

FIBTEM provides early prediction of massive transfusion in trauma

Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time

Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients

Regulation of endothelial cell t-PA synthesis and release.

P304

45-49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/SHK.0B013E3182787122

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P50

Anirban Banerjee

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23247121

http://www.w3.org/2001/XMLSchema#string

P932

3529156

http://www.w3.org/2001/XMLSchema#string